| [1] |
Aaltonen LA，Peltomaki P，Leach FS，et al.Clues to the pathogenesis of familial colorectal cancer.Science，1993,260(5109):812-816.
|
| [2] |
Ionov Y，Peinado MA，Malkhosyan S，et al.Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.Nature，1993,363(6429):558-561.
|
| [3] |
Sargent DJ，Marsoni S，Monges G，et al.Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.J Clin Oncol，2010,28(20):3219-3226.
|
| [4] |
Chapelle A，Hampel H．Clinical relevance of microsatellite instability in colorectal cancer.J Clin Oncol，2010,28(20):3380-3387.
|
| [5] |
Lindor NM，Rabe K，Petersen GM，et al.Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency：familial colorectal cancer type X．JAMA，2005,293(16):1979-1985.
|
| [6] |
Boland CR，Thibodeau SN，Hamilton SR，et al.A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition：development of international criteria for the determination of microsatellite instability in colorectal cancer.Cancer Res，1998,58(22):5248-5257.
|
| [7] |
Markowitz S，Wang J，Myeroff L，et al.Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.Science，1995,268(5215):1336-1338.
|
| [8] |
Kempers MJ，Kuiper RP，Ockeloen CW，et al.Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome：a cohort study.Lancet Oncol，2011,12(1):49-55.
|
| [9] |
Baglietto L，Lindor NM，Dowty JG，et al.Risks of Lynch syndrome cancers for MSH6 mutation carriers.J Natl Cancer Inst，2010,102(3):193-201.
|
| [10] |
Sinicrope FA，Foster NR，Thibodeau SN，et al.DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.J Natl Cancer Inst，2011,103(11):863-875.
|
| [11] |
Mvundura M，Grosse SD，Hampel H，et al.The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.Genet Med，2010,12(2):93-104.
|
| [12] |
Hampel H，Frankel WL，Martin E，et al.Screening for the Lynch syndrome(hereditary nonpolyposis colorectal cancer)．N Engl J Med，2005,352(18):1851-1860.
|
| [13] |
Hampel H，Frankel WL，Martin E，et al.Feasibility of screening for Lynch syndrome among patients with colorectal cancer.J Clin Oncol，2008,26(35):5783-5788.
|
| [14] |
Mecklin JP，Jarvinen HJ，Peltokallio P．Cancer family syndrome.Genetic analysis of 22 Finnish kindreds.Gastroenterology，1986,90(2):328-333.
|
| [15] |
Thibodeau SN，Bren G，Schaid D．Microsatellite instability in cancer of the proximal colon.Science，1993,260(5109):816-819.
|
| [16] |
Lothe RA，Peltomaki P，Meling GI，et al.Genomic instability in colorectal cancer：relationship to clinicopathological variables and family history.Cancer Res，1993,53(24):5849-5852.
|
| [17] |
Gryfe R，Kim H，Hsieh ET，et al.Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.N Engl J Med，2000,342(2):69-77.
|
| [18] |
Halling KC，French AJ，McDonnell SK，et al.Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.J Natl Cancer Inst，1999,91(15):1295-1303.
|
| [19] |
Kakar S，Aksoy S，Burgart LJ，et al.Mucinous carcinoma of the colon：correlation of loss of mismatch repair enzymes with clinicopathologic features and survival.Mod Pathol，2004,17(6):696-700.
|
| [20] |
Popat S，Hubner R，Houlston RS.Systematic review of microsatellite instability and colorectal cancer prognosis.J Clin Oncol，2005,23(3):609-618.
|
| [21] |
Wynte CVA.Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability.The Journal of Pathology，1999,189(3):319-325.
|
| [22] |
Wendum D，Boelle PY，Rigau V，et al.Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.Virchows Arch，2003,442(2):111-117.
|
| [23] |
Moertel CG，Fleming TR，Macdonald JS，et al.Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.N Engl J Med，1990,322(6):352-358.
|
| [24] |
Wolmark N，Rockette H，Mamounas E，et al.Clinical trial to assess the relative efficacy of fluorouracil and leucovorin，fluorouracil and levamisole，and fluorouracil，leucovorin，and levamisole in patients with Dukes' B and C carcinoma of the colon：results from National Surgical Adjuvant Breast and Bowel Project C-04.J Clin Oncol，1999,17(11):3553-3559.
|
| [25] |
Wolmark N，Rockette H，Fisher B，et al.The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer：results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.J Clin Oncol，1993,11(10):1879-1887.
|
| [26] |
O'Connell MJ，Laurie JA，Kahn M，et al.Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.J Clin Oncol，1998,16(1):295-300.
|
| [27] |
Gray R．QUASAR：A randomized study of adjuvant chemotherapy(CT)vs observation including 3238 colorectal cancer patients.Journal of Clinical Onccology，2004:a3501.
|
| [28] |
Sargent DJ.Confirmation of deficient mismatch repair(dMMR)as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer(CC)：A pooled molecular reanalysis of randomized chemotherapy trials.Journal of Clinical Oncology，2008,26(15S):a4008.
|
| [29] |
Arnold CN，Goel A，Boland CR.Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.Int J Cancer，2003,106(1):66-73.
|
| [30] |
Pocard M，Bras-Goncalves R，Hamelin R，et al.Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability：influence of P53 status.Anticancer Res，2000,20(1A):85-90.
|
| [31] |
Benson AB，New approaches to assessing and treating early-stage colon and rectal cancers：cooperative group strategies for assessing optimal approaches in early-stage disease.Clin Cancer Res，2007,13(22):6913-6920.
|